Spence (@spencemacdon) 's Twitter Profile
Spence

@spencemacdon

ID: 191161878

calendar_today15-09-2010 19:12:53

111 Tweet

65 Followers

382 Following

GenomeBC (@genomebc) 's Twitter Profile Photo

Our Pilot Innovation Fund offers investment& provides mentorship! We're delighted to support Isolatrix (University of British Columbia BC Cancer) GPS-seq (UBC) protein analysis tech (Reuven Gordon UniversityOfVictoria) Tope-seq (BCCancer) & converting blood group for transplant (@ABOzymes) More genomebc.ca/blog/genome-bc…

ACS Central Science (@acscentsci) 's Twitter Profile Photo

#ASAP by Jay Kizhakkedathu Lab, Dirk Lange & team A silver-based biocompatible coating with sustained release, long-term zero bacterial adhesion, and high durability applicable to diverse biomedical materials/devices was prepared in a single step go.acs.org/Zo

#ASAP by <a href="/JayKizLab/">Jay Kizhakkedathu Lab</a>, <a href="/DLangePhD/">Dirk Lange</a> &amp; team

A silver-based biocompatible coating with sustained release, long-term zero bacterial adhesion, and high durability applicable to diverse biomedical materials/devices was prepared in a single step go.acs.org/Zo
LBNL BioSci (@lbnlbiosci) 's Twitter Profile Photo

Researchers from Joint Genome Institute and Joint BioEnergy Institute (JBEI) were part of a team that identified a bacterial enzyme that produces a novel biopolymer called acholetin, similar to the major component of insect exoskeletons bit.ly/3OE5o9F

Researchers from <a href="/jgi/">Joint Genome Institute</a> and <a href="/jbei/">Joint BioEnergy Institute (JBEI)</a> were part of a team that identified a bacterial enzyme that produces a novel biopolymer called acholetin, similar to the major component of insect exoskeletons
bit.ly/3OE5o9F
Joel Beasley (@moderncto_io) 's Twitter Profile Photo

Peter Rahfeld, Co-founder & CSO at @ABOzymes, talks about transforming blood types by altering the antigens in the blood. Check out the full episode now! ecs.page.link/7nWJK #cto #medtech #innovation

AdvancedLightSource (@advlightsource) 's Twitter Profile Photo

Researchers discovered an enzyme that synthesizes a biopolymer similar to chitin, but linked in a different way. The polymer is biodegradable and may be biocompatible, with potential applications ranging from medical therapeutics to plastic alternatives. als.lbl.gov/bacterial-enzy…

Researchers discovered an enzyme that synthesizes a biopolymer similar to chitin, but linked in a different way. The polymer is biodegradable and may be biocompatible, with potential applications ranging from medical therapeutics to plastic alternatives. als.lbl.gov/bacterial-enzy…
Techcouver (@techcouver) 's Twitter Profile Photo

ABOzymes Raises Seed Round To Fund Tech For Universal Blood Tranfusions ⁦@ABOzymes⁩ #bctech techcouver.com/2022/06/23/abo…

GlycoNet (@glyconet_nce) 's Twitter Profile Photo

After more than two years of limited in-person opportunities for knowledge sharing and networking, GlycoNet was proud to host the 2022 Canadian Glycomics Symposium. Read some highlights from the event: bit.ly/3nydvrN #glycotime #glycomics

After more than two years of limited in-person opportunities for knowledge sharing and networking, GlycoNet was proud to host the 2022 Canadian Glycomics Symposium. Read some highlights from the event: bit.ly/3nydvrN
#glycotime #glycomics
Michael Smith Labs (@ubcmsl) 's Twitter Profile Photo

🥳 Congratulations to Drs Stephen Withers (WithLab), Peter Rahfeld Peter Rahfeld and collaborators on their successful seed funding to support their groundbreaking inroads with blood type antigen conversion at @ABOzymes. 🩸 👏 UBC Centre for Blood Research #Glycomics #BloodTransfusion #health

Avivo Biomedical Inc. (@avivobio) 's Twitter Profile Photo

ABOzymes is now Avivo! Avivo means “from life and for life”. This name update reflects the evolution of the company, while maintaining our founding vision. Visit our new website: avivobio.com and be sure to play the video on the homepage.

GenomeBC (@genomebc) 's Twitter Profile Photo

Here’s a scary-good story: we’re funding an Avivo Biomedical Inc. project that is testing an innovative technology to convert A blood types to O – paving the way to universal blood and organ transplants. If successful, this would be a life-saving leap forward. Have a🩸good #Halloween.

Here’s a scary-good story: we’re funding an <a href="/AvivoBio/">Avivo Biomedical Inc.</a> project that is testing an innovative technology to convert A blood types to O – paving the way to universal blood and organ transplants. If successful, this would be a life-saving leap forward. 

Have a🩸good #Halloween.
Life Sciences BC (@lifesciences_bc) 's Twitter Profile Photo

Member Spotlight: Avivo Biomedical Inc. (formerly ABOzymes), a British Columbia-based preclinical-stage company, has identified enzymes that convert the cell surface antigens that determine a person’s blood group to group O, the universal donor type. bit.ly/3EdkDmC

Member Spotlight: <a href="/AvivoBio/">Avivo Biomedical Inc.</a> (formerly ABOzymes), a British Columbia-based preclinical-stage company, has identified enzymes that convert the cell surface antigens that determine a person’s blood group to group O, the universal donor type. bit.ly/3EdkDmC
Eric Topol (@erictopol) 's Twitter Profile Photo

How a gut bacteria could make blood of all types universal, radically changing transfusion medicine nature.com/articles/s4156… nature.com/articles/s4156… Nature Microbiology

How a gut bacteria could make blood of all types universal, radically changing transfusion medicine
nature.com/articles/s4156…
nature.com/articles/s4156…
<a href="/NatureMicrobiol/">Nature Microbiology</a>
Rhea Bains (@rheabains) 's Twitter Profile Photo

Super proud of my labmate Amir (not on twitter), and others for publishing this beautiful story in Nature! It's been so great seeing this project evolve over the years! Highly recommend reading this one! WithLab BrumerLab Michael Smith Labs @ubcchem #glycotime nature.com/articles/s4158…

Science in Vancouver (@sciencevancity) 's Twitter Profile Photo

Dr. Seyed Amirhossein Nasseri and tge Withers' lab (WithLab) at University of British Columbia are making waves with their latest publication! 🌊 Their work on identifying an alternative pathway for glycan degradation is featured on the latest Immunology Podcast episode! 🎧: bit.ly/4ePiaPO

Dr. Seyed Amirhossein Nasseri and tge Withers' lab (<a href="/withlabb/">WithLab</a>) at <a href="/UBC/">University of British Columbia</a> are making waves with their latest publication! 🌊

Their work on identifying an alternative pathway for glycan degradation is featured on the latest <a href="/ImmunoPodcast/">Immunology Podcast</a> episode! 

🎧: bit.ly/4ePiaPO